Addus HomeCare Corporation (ADUS) is a leading medical care facilities business based in the US. Addus HomeCare is listed on the NASDAQ and employs 5,002 staff. All prices are listed in US Dollars.
|52-week range||$43.125 - $127.99|
|50-day moving average||$115.1864|
|200-day moving average||$100.8939|
|Wall St. target price||$128.25|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$2.224|
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Valuing Addus HomeCare stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Addus HomeCare's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Addus HomeCare's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 57x. In other words, Addus HomeCare shares trade at around 57x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Addus HomeCare's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.466. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Addus HomeCare's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Addus HomeCare's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $64.9 million.
The EBITDA is a measure of a Addus HomeCare's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$760.8 million|
|Operating margin TTM||6.94%|
|Gross profit TTM||$178.9 million|
|Return on assets TTM||5.02%|
|Return on equity TTM||7.25%|
|Market capitalisation||$2 billion|
TTM: trailing 12 months
There are currently 262,363 Addus HomeCare shares held short by investors – that's known as Addus HomeCare's "short interest". This figure is 27.1% up from 206,466 last month.
There are a few different ways that this level of interest in shorting Addus HomeCare shares can be evaluated.
Addus HomeCare's "short interest ratio" (SIR) is the quantity of Addus HomeCare shares currently shorted divided by the average quantity of Addus HomeCare shares traded daily (recently around 103700.79051383). Addus HomeCare's SIR currently stands at 2.53. In other words for every 100,000 Addus HomeCare shares traded daily on the market, roughly 2530 shares are currently held short.
However Addus HomeCare's short interest can also be evaluated against the total number of Addus HomeCare shares, or, against the total number of tradable Addus HomeCare shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Addus HomeCare's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Addus HomeCare shares in existence, roughly 20 shares are currently held short) or 0.0202% of the tradable shares (for every 100,000 tradable Addus HomeCare shares, roughly 20 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Addus HomeCare.
Find out more about how you can short Addus HomeCare stock.
We're not expecting Addus HomeCare to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Over the last 12 months, Addus HomeCare's shares have ranged in value from as little as $43.125 up to $127.99. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Addus HomeCare's is 0.6345. This would suggest that Addus HomeCare's shares are less volatile than average (for this exchange).
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates in three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment's services include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. As of June 30, 2020, the company served consumers through 190 offices located in 25 states. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.